Why Is Skyrizi So Hard to Find? [Explained for 2026]

If you've been prescribed Skyrizi (risankizumab) and run into roadblocks trying to fill it, you're not alone. Unlike most medications you can pick up at a corner pharmacy, Skyrizi is a specialty biologic—and getting access to it involves a process that can feel frustrating and confusing. This guide explains exactly why Skyrizi is so difficult to access in 2026 and what you can do about it.

What Is Skyrizi and Why Is It Different from Regular Medications?

Skyrizi is a biologic medication—a large-molecule drug made from living cells—used to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis in adults. It works by blocking a protein called interleukin-23 (IL-23) that drives inflammation in these conditions.

Because Skyrizi is a complex biologic injectable—not a simple pill—it falls into a completely different category than most medications. It must be kept refrigerated, requires injection training, needs regular medical monitoring, and carries risks that require close clinical oversight. These factors combine to make it a "specialty" medication under nearly every insurance plan.

Why Does Skyrizi Require Prior Authorization?

Prior authorization (PA) is the biggest single barrier most patients face when trying to get Skyrizi. Almost every commercial insurance plan, Medicare plan, and Medicaid program requires PA before they will cover Skyrizi. This means your doctor must submit clinical documentation to your insurer proving that Skyrizi is medically necessary for your specific situation.

Insurance companies require prior authorization for Skyrizi for several reasons:

The list price of Skyrizi is approximately $22,000 per dose—making it one of the most expensive medications on the market

Insurers want to verify you have an approved diagnosis (moderate to severe psoriasis, active PsA, CD, or UC)

Many plans require documentation of disease severity (e.g., body surface area involvement, PASI score)

Some plans require tuberculosis (TB) screening results to be on file before approving Skyrizi

The PA process can take anywhere from a few days to several weeks, depending on your insurer. Standard reviews at most major insurers take 7 to 45 days, while expedited reviews for urgent situations may be completed within 24 to 72 hours. Delays in submitting complete documentation—missing TB screening results, inadequate disease severity documentation, or incomplete specialist notes—are the most common reasons PA approvals get held up.

What Is Step Therapy and Why Does It Apply to Skyrizi?

Step therapy (sometimes called "fail first" policy) is a major reason patients can't get Skyrizi right away, even when their doctor prescribes it. Under step therapy, your insurance plan requires you to try—and fail—one or more less expensive drugs before they'll approve Skyrizi.

For Skyrizi, this most commonly means you need documented failure of at least one TNF inhibitor biologic (such as Humira or Enbrel) first. Some plans require failure of a conventional therapy like methotrexate or phototherapy before you can even try a TNF inhibitor. The result is that many patients who could benefit from Skyrizi immediately end up spending months trying other treatments first—not because those treatments are better, but because insurers want to protect against high-cost prescriptions when cheaper options might work.

Your specialist can sometimes request a step therapy exception if there is clinical justification for skipping this step—for example, if a contraindication to TNF inhibitors exists, or if you already tried them previously.

Why Is Skyrizi Only Available Through Specialty Pharmacies?

Unlike a pill you can pick up at any local pharmacy, Skyrizi is only dispensed through designated specialty pharmacies. A specialty pharmacy has specialized staff trained to handle complex biologics, provide patient counseling on injection technique, coordinate with your insurance on prior authorization, and arrange refrigerated delivery to your home.

Many insurance plans have specific contracted specialty pharmacies you must use for Skyrizi. For example, Aetna plans typically require CVS Specialty, while other plans may mandate their own network pharmacies. If your prescription is sent to the wrong pharmacy, it won't be filled—adding unnecessary delays. For Crohn's and UC patients whose initial doses are given as IV infusions, those doses are administered in a clinical setting (hospital or infusion center), not at home.

What Happens If Your Insurance Denies Skyrizi?

Denials are common with specialty biologics like Skyrizi, but a denial is not the end of the road. Here are your options:

File an internal appeal: Most insurance plans give you the right to appeal a denial within 180 days. Your doctor can submit additional documentation supporting medical necessity.

Request a peer-to-peer review: Your prescribing specialist can speak directly with the insurance company's medical director to argue your case—often resulting in approval.

Request an external review: If internal appeals fail, you may have the right to an independent external review, which is binding on the insurer.

AbbVie's bridge program: If your insurance approval is delayed more than 5 business days or is denied, AbbVie's Skyrizi Complete program may provide your medication at no charge while you work through the appeals process (for eligible commercially insured patients 63 or younger).

How Can You Track Down Your Skyrizi Prescription Faster?

When you're dealing with specialty pharmacy logistics on top of prior authorization delays, having help tracking down your medication matters. medfinder is a paid service that calls pharmacies on your behalf to find which ones can fill your Skyrizi prescription—saving you the time and frustration of making those calls yourself.

Here are additional steps to speed up access:

Ask your dermatologist, rheumatologist, or gastroenterologist to submit the PA with complete documentation upfront—including TB screening, disease severity measures, and prior treatment history

Enroll in Skyrizi Complete (call 1-866-SKYRIZI) for personalized insurance navigation support and a dedicated Nurse Ambassador

Confirm which specialty pharmacy your insurer requires—and send the prescription there directly

If you're uninsured or underinsured, apply for myAbbVie Assist to receive Skyrizi at no cost if you meet income requirements

The Bottom Line on Skyrizi Access in 2026

Skyrizi isn't hard to find because it's in short supply—it's hard to access because it's a high-cost specialty biologic with multiple administrative barriers. Prior authorization, step therapy requirements, and specialty pharmacy restrictions are the primary reasons patients struggle to get it. The good news is that there are clear steps to navigate each of these barriers, strong manufacturer support programs to help with costs and logistics, and advocacy tools available when insurance denials happen. See our guide on how to save money on Skyrizi in 2026 for more on keeping your out-of-pocket costs manageable.